http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07252163-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 1994-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e13115f29b93c22cfb17166dd539464a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c2ef8c96cd7eba85871bd4f60b72ddd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a62dffc9d0c2f47bea0ad6182d96c61 |
| publicationDate | 1995-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H07252163-A |
| titleOfInvention | Thrombocytopenia treatment |
| abstract | (57) [Summary] [Objective] To provide a novel therapeutic agent for thrombocytopenia. [Structure] General formula [Chemical formula 1] [Wherein R 1 and R 2 each represent hydrogen or an aliphatic acyl group, R 3 represents an aliphatic acyl group, R 4 represents hydrogen or a protective group, and X represents 1 which may have a protective group. Which shows an amino acid sequence consisting of 10 amino acid residues], or a therapeutic agent for thrombocytopenia containing a compound represented by the formula: or a salt thereof. [Effect] The thrombocytopenia therapeutic agent of the present invention is used as a therapeutic agent for thrombocytopenia caused by radiotherapy or chemotherapy for cancer of mammals (eg, human, monkey, horse, cow, cat, dog, etc.). Further, it can be safely used for the treatment of thrombocytopenia after bone marrow transplantation and the prevention or treatment of autoimmune diseases accompanied by thrombocytopenia (eg, aplastic anemia, idiopathic thrombocytopenic purpura, etc.). |
| priorityDate | 1994-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 261.